EUVIMEDEUVIMED entdecken
Open Access

Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence

Xuanhua P Xie, Mungunsarnai Ganbold, Jing Li, Michelle Lien, Mollie E Chipman, Tao Wang, Chenura D Jayewickreme, Alicia M Pedraza, Tejus Bale, Viviane Tabar, Cameron Brennan, Daochun Sun und 2 weitere

Neuron · 2024-12 · 112 (24) · 4017-4032.e6

DOI: 10.1016/j.neuron.2024.10.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2024-12. Verfasst von Xuanhua P Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology & Genetics Program, Memorial Sloan Kettering Canc…. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Neoplasm Recurrence, Local, Brain Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, American Brain Tumor Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is an incurable disease with high intratumoral heterogeneity. Bioinformatic studies have examined transcriptional heterogeneity with differing conclusions. Here, we characterize GBM heterogeneity and highlight critical phenotypic and hierarchical roles for quiescent cancer stem cells (qCSCs). Unsupervised single-cell transcriptomic analysis of patient-derived xenografts (PDXs) delineates six GBM transcriptional states with unique tumor exclusive gene signatures, five of which display congruence with central nervous system (CNS) cell lineages. We employ a surrogate tumor evolution assay by serial xenograft transplantation to demonstrate faithful preservation of somatic mutations, transcriptome, and qCSCs. PDX chemotherapy results in CSC resistance and expansion, also seen in recurrent patient GBM. In aggregate, these novel GBM transcriptional signatures exclusively identify tumor cells and define the hierarchical landscape as stable biologically discernible cell types that allow capture of their evolution upon recurrence, emphasizing the importance of CSCs and demonstrating general relevance to all GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsNeoplasm Recurrence, LocalBrain NeoplasmsHumansAnimalsMiceSingle-Cell AnalysisTranscriptomeGenetic Heterogeneity

Stichwörter der Autor:innen

F3 receptorcancer stem cellschemoresistanceglioblastomaheterogeneityhierarchypatient-derived xenograftrecurrencesingle-cell RNA sequencingtemozolomide

Autor:innen und Institutionen

  • Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Eppley Institute for Research in C…
  • Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • American Brain Tumor Association
  • National Cancer Institute
  • Cancer Research UK

Zitieren

APA

Xie, X. P., Ganbold, M., Li, J., Lien, M., Chipman, M. E., Wang, T., Jayewickreme, C. D., Pedraza, A. M., Bale, T., Tabar, V., Brennan, C., Sun, D., Sharma, R., & Parada, L. F. (2024). Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence. Neuron, 112(24), 4017-4032.e6. https://doi.org/10.1016/j.neuron.2024.10.012

Vancouver

Xie XP, Ganbold M, Li J, Lien M, Chipman ME, Wang T, et al. Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence. Neuron. 2024;112(24):4017-4032.e6. doi:10.1016/j.neuron.2024.10.012

BibTeX
@article{Xie2024,
  author = {Xie, Xuanhua P and Ganbold, Mungunsarnai and Li, Jing and Lien, Michelle and Chipman, Mollie E and Wang, Tao and Jayewickreme, Chenura D and Pedraza, Alicia M and Bale, Tejus and Tabar, Viviane and Brennan, Cameron and Sun, Daochun and Sharma, Roshan and Parada, Luis F},
  title = {Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence},
  journal = {Neuron},
  year = {2024},
  volume = {112},
  number = {24},
  pages = {4017--4032.e6},
  doi = {10.1016/j.neuron.2024.10.012}
}
Kostenlos starten →